The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer

European Journal of Endocrinology

Volumn 155, Issue 6, 2006, Pages 801-806

  Verkooijen, Robbert B T ^a   Smit, Jan W A ^a   Romijn, Johannes A ^a   Stokkel, Marcel P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADRENAL CANCER; ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; KIDNEY CARCINOMA; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NETHERLANDS; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CANCER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; SALIVARY GLAND CANCER; SECOND CANCER; STOMACH CANCER; SURVIVAL RATE; THYROID CANCER; UNIVERSITY HOSPITAL; UROGENITAL TRACT CANCER; UTERINE CERVIX CANCER;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PREVALENCE; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33845973709     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02300     Document Type: Article

References (27)

1. Adjadj E, Rubino E, Shamdaldim A, le Monique G, Schlumberger M & de Vathaire F. The risk of multiple primary breast and thyroid carcinomas: role of radiation dose. Cancer 2003 98 1309-1317.
2. Agrawal S & Eng C. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Human Molecular Genetics 2006 15 777-787.
3. Bau MG, Arisio R, Cristini G, Bertone E & Campgrande M. Screening-detected breast carcinoma in a patient with Cowden syndrome. Breast 2004 13 239-241.
4. Berthe E, Henry-Amar M, Michel J-J, Rame J-P, Berthet P, Babin E, Icard P, Samama G, Galateau-Salle F, Mahoudeau J & Bardet S. Risk of second primary cancer following differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging 2004 31 685-691.
5. Broaddus RR, Lynch PM, Lu KH, Luthra R & Michelson SJ. Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome. Modern Pathology 2004 17 981-989.
6. Cengiz O, Bozkurt B, Unal B, Yildrim O, Karaeyoglu M, Eroglu A, Kocer B & Ulas M. The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. Journal of Surgical Oncology 2004 87 19-25.
7. Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Szymanska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narond SA & Lubinski J. CHEK2 is a multiorgan cancer susceptibility gene. American Journal of Human Genetics 2004 75 1131-1135.
8. Duchateau CSJ & Stokkel MPM. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival. Chest 2005 127 1152-1158.
9. Fisher LW, Jain A, Tayback M & Fedarko SN. Small integrin binding ligand N-linked glycoproteins gene family expression in different cancers. Clinical Cancer Research 2004 10 8501-8511.
10. Gilliland FD, Hunt WC, Morris DM & Key CR. Prognostic factors in thyroid carcinoma. A population-based study of 15 698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer 1997 79 564-573.
11. Hemminki K & Li X. Familial risk of cancer by site and histopathology. International Journal of Cancer 2003 103 105-109.
12. Hemminki K & Chen B. Familial association of colorectal adenocarcinoma with cancers at other sites. European Journal of Cancer 2004 40 2480-2487.
13. Levene S, Scott G, Price P, Sandersom J, Evans H, Taylor C, Bass S, Lewis C & Hodgson S. Does the occurrence of certain rare cancers indicate and inherited cancer susceptibility? Familial Cancer 2003 2 15-25.
14. Pal T, Hamel N, Vespirini D, Sanders K, Mitchell M, Quercia N, Ng Cheong N, Murray A, Foulkes WD & Narod SA. Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications. Familial Cancer 2001 1 17-24.
15. Pluijmen MJH, Eustatia-Rutten C, Goslings B, Stokkel MP, Pereira Arias AM, Diamant M, Romijn JA & Smit JWA. Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma. Clinical Endocrinology 2003 58 428-435.
16. Puxeddu E, Zhao G, Stringer JR, Medvedovic M, Moretti S & Fagin JA. Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens. Mutation Research 2005 570 17-32.
17. Reingold SR, Neugut AI & Meadows AT. Second cancers: incidence, risk factors and management. In Cancer Medicine, pp 2399-2406. Eds JF Holland, E Frei, RE Pollock, RR Weichselbaum, RC Bast & DW Kufe: Hamilton, ON, Canada, 2000.
18. Ronckers CM. Thyroid cancer and multiple primary tumors in the SEER cancer registries. International Journal of Cancer 2005 117 281-288.
19. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C & Schlumberger M. Second primary malignancies in thyroid cancer patients. British Journal of Cancer 2003 89 1638-1644.
20. Sadetzki S, Calderon-Margalit R, Peretz C, Novikov I, Barchana M & Papa MZ. Second primary breast cancer and thyroid disorders. Cancers Causes and Control 2002 14 367-375.
21. Sandeep TC, Strachan MWJ, Reynolds RM, Brewster DR, Scelo G, Pukkula E, Hemminki K, Anderson A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita. JM, Jonasson JG, Martos C, Bofetta P & Brennan P. Second primary cancers in thyroid cancer patients: a multinational record linkage study. Journal of Clinical Endocrinology and Metabolism 2006 91 1819-1825.
22. Schlumberger MJ. Papillary and follicular thyroid carcinoma. New England Journal of Medicine 1998 338 297-306.
23. Simon M, Tang M-TC, Berstein L, Norman SA, Weiss L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone K, Marchbanks PA, McDonald JA, Strom BL, Wilson HG & Spirtas R. Do thyroid disorders increase the risk of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2002 11 1574-1578.
24. Vassilopoulou-Sellin R, Palmer L, Palmer S, Taylor S & Cooksley CS. Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 1999 85 696-705.
25. Verkooijen RBT, Stokkel MPM, Smit JWA & Pauwels EKJ. Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy. European Journal of Nuclear Medicine and Molecular Imaging 2004 31 499-506.
26. Weiss M, Zaretsky J, Zimlichman R, Smorodinsky N, Dion AS, Keydar I & Wreschner DR. Expression of a gene coding for breast tumor-associated antigen in thyroid papillary carcinoma. Cancer Letters 1991 58 125-130.
27. Zaretsky JZ, Weiss M, Tsarfaty I. Hareuveni M, Wreschner DH & Keydar I. Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. FEBS Letters 1990 253 46-50.